Epidemiology
Of 10 million adults throughout the world with HIV infection, 75% have been infected through heterosexual transmission. This has resulted in an increasing number of women who have been infected, and with it, a rise in the numbers of children. Children under the age of 13 years with AIDS represent about 2% of all the total cases reported to the World Health Organisation. Reporting cases ofAIDS underestimates the size of the problem, and it is estimated that there are about one million children throughout the world infected with HIV.
In sub-Saharan Africa, some 900,000 infants have been estimated by WHO to have been bom infected with HIV. In Latin America, about 10,000 children are infected as a result of vertical transmission. The numbers of infected children in South and South-East Asia are not known, but the virus is spreading rapidly through heterosexual intercourse and by the end of this century, more Asians may be infected each year than Africans.
In the USA, the numbers of paediatric AIDS cases rose four-fold between 1985 and 1990 , and at the end of February 1992, there were 3,406 cases of AIDS reported in children, the majority infected as a result of vertical transmission.
In Europe, paediatric AIDS cases are concentrated in Romania, France, Italy and Spain. As of March 1991, 2338 cases had been notified to the WHO Collaborating Center on AIDS, half of whom were Romanian orphans infected by horizontal transmission. 4 With the exception of Romania, the majority (77%) of children have been infected by mother-to-child transmission of HIV.
In the United Kingdom 370 children under 15 years of age have been infected with HIV, 64% of whom are children with coagulation disorders. 5 With the introduction of donor screening and heat treatment of blood products, no new cases have been documented where infection occurred through transfusion. Although only 107 children were reported to have mother-to-child transmission as a risk factor, the increase in the number of women of child bearing age with HIV infection is likely to result in an increase in the numbers of infected children. Recent surveys of matemal HIV infection, using anonymous unlinked samples from newborn babies, revealed a seroprevalence of 0 59 per 1,000 in the Thames regions and 0.29 per 1,000 in Scotland as a whole. Within these areas, inner London and Edinburgh were shown to have particular problems, with seroprevalence figures of 1.26 and 2-46 per 1,000 respectively, during 1990. 6 7 Routes of transmission The principle routes of HIV infection, for the paediatric population are: (1) Mother-to-child, or vertical, transmiission, (2) Nosocomial spread through the use of inadequately sterilised needles and syringes, (3) Transfusion of unscreened blood and untreated blood products. Child sexual abuse has been associated with HIV transmission in a small number of cases. The importance of this route of transmission has yet to be determined. 8 Although intrauterine transmission is undisputed, the actual timing of infection is unclear. Descriptions of dysmorphic features suggest early (first or second trimester) infection,9 and HIV antigen has been identified in fetal and placental tissue from eighth week abortuses.'Ò n the other hand, reports of children presenting with the slowly progressive form of HIV disease suggest that infection may have been acquired round about the time of delivery.
Several prospective studies undertaken in Europe, USA and Africa of children born to HIV infected women, have reported the rate of mother-to-child transmission of 13-40%."-'3
These variations may be partially explained by different enrolment criteria; different methods used to define HIV infection in the young child; differing lengths of follow-up of the cohort, as well as by differences in the clinical and immunological status ofthe mothers at the time of delivery. A combination of maternal, fetal and virological factors is likely to influence the risk of HIV transmission from mother to child.
Despite the abundance of infected blood and amniotic fluid during delivery, intrapartum infection has not been documented to occur. Prospective follow-up studies of large cohorts of children born to HIV infected women have not demonstrated a protective effect of Caesarean section. Interestingly, a recent report from the International Registry of HIV-exposed twins showed that 50% of first born twins delivered per vaginum and 38% of firstborns delivered by Caesarean section were HIV infected, compared with 19% of second borns delivered by either route. The authors postulated that as the first twin passed through the cervix and birth canal, exposure to maternal blood and fluids resulted in a higher incidence of infection, compared with the second twin.'4 The relative importance of transmission at delivery is emerging, and deserves further study as there are obvious implications for the interruption of mother-tochild transmission by vaccination.
It has been established that breast feeding during acute HIV infection in the post-partum period poses a risk to the infant. ' (b) HIV culture The virus can be cultured from peripheral blood mononuclear cells, or plasma. Although a positive culture remains the gold standard diagnostic test, its usefulness is limited as cultures generally take 7-28 days to complete, are costly and labour intensive, and requires special safety precautions for the laboratory personnel. Also, it requires a relatively large volume of blood, making it less practical in neonatal practice. The decreased sensitivity of the test, due to small volumes of blood or to low virus load in asymptomatic individuals, means that a negative culture result does not necessarily exclude HIV infection.
(c) HIV antigen HIV core antigen can be detected using commercially available kits. In the presence of high titres of HIV specific antibody, however, antigen is complexed to the antibody and is therefore undetectable. Studies of infants born to HIV infected mothers have found very few infants to be antigen positive early in the course of disease, owing to the presence of maternal antibody.`' HIV antigen is usually detected at specific points in the natural history of the disease-prior to seroconversion and in the terminal stages of the disease. The concentration of core antigen correlates with virus load, and is sometimes used to monitor the effect of antiviral therapy; as well as a prognostic marker of disease progression.
(d) Polymerase chain reaction This promising technique amplifies HIV-DNA a millionfold to increase the probability of detection. It allows detection of ten molecules of viral DNA in 1 ug of human DNA, or one HIV-DNA molecule in 100,000 mononuclear cells.
Although highly sensitive, the method has its limitations, which has prevented its routine use. False positive results arise from contamination, and the technique is labour intensive. Early investigators have reported discordant results when comparing PCR methods with HIV culture and antigen detection.``It is likely that the sensitivity of PCR varies during the course of HIV infection, being least sensitive when the individual is asymptomatic.2( e) "Surrogate tests" For many children, non-specific laboratory abnormalities usually alert the paediatrician to a diagnosis of HIV infection. Polyclonal hypergamma-globulinaemia has been reported to be an early and specific indicator of HIV infection." 22 In the European Collaborative Study about 40% of infected children showed evidence of raised gammaglobulin levels by three months. By six months, hypergammaglobulinaemia was shown to be a reliable predictor of infection, with a sensitivity 77% and specificity of 97%. At the same age, low CD4/CD8 ratio was found to have a sensitivity of 31% and a specificity of 99%. Decreased CD4+ T cells and a low ratio of CD4/CD8 T cells usually occur late in paediatric HIV disease. However, no large studies have been performed to define the normal ranges for CD4 and CD8 cells in children.
Thrombocytopaenia may be the presenting feature in many HIV infected children. Indeed, these children are often seen by haematologists and treated as "immune thrombocytopaenia" prior to HIV testing.
Clinical presentation
Children who have haemophilia and HIV infection resemble adults in the incubation period and clinical manifestations of the disease; and their clinical presentation will not be discussed in this section. For those infected by mother-to-child transmission, the mean incubation period is about 2-3 years (90% confidence interval 1*9-3P1 years), although children presenting at an older age have been reported. Despite infection occurring in utero, clinical disease is rarely seen in the neonatal period, apart from the dysmorphic features described by workers from New York.' The existence of this "fetal AIDS syndrome" remains controversial.
In perinatally-infected children, retrospective reviews and prospective studies have delineated a bimodal distribution in the clinical spectrum. In the USA, two retrospective reviews23 24 of cohorts of children showed that 80% presented with a severe infantile form of the disease. The median age at diagnosis was 8 months; median survival from birth 77 months, and from diagnosis, 38 months. Scott and her co-workers showed that the AIDS indicator disease influenced survival, with
Pneumocystis carinii pneumonia claiming the highest mortality in infants less than a year old.23The prospective European Collaborative Study, confirmed the bimodal clinical picture." By 12 months, 26% of 64 infected children had developed AIDS, with a mortality of 17% during the first year. Thereafter, the disease progression slowed down considerably, with the rest of the infected children remaining stable with the "slowly progressive" form of HIV disease. The natural history of this form of the disease remains to be elucidated, although it is doubtful if natural history studies would remain ethical, in the presence of therapeutic advances. It is more likely that the "unnatural history" will unfold, as antiretroviral therapies are used in children.
For Opportunistic infections are the hallmark of AIDS, the commonest being Pneumocystis carinii pneumonia (PCP). The diagnosis of PCP is usually invasive and hazardous in an ill child, but the use of monoclonal antibodies has allowed detection of pneumocystis antigen from nasopharyngeal secretions, obviating the need for bronchoalveolar lavage or lung biopsy in the very sick child. 29 Oral candida can lead to dissemination throughout the gastrointestinal tract, resulting in anorexia and dysphagia. Other opportunistic organisms which cause disseminated antenatal care amongst HIV infected pregnant women demand a high level of coordination between medical, obstetric and paediatric staff in order to ensure that both mother and child are followed up. The model in Edinburgh is that of a family clinic, with home visits made if necessary.'2 The paediatrician is usually introduced to the woman in the antenatal period, to discuss issues surrounding mother-to-child transmission. The paediatrician is present soon after delivery, to examine the child and obtain relevant specimens. Future visits are then arranged.
All infants born to HIV infected women should be followed up intensively in the first year of life, with regular clinical examinations and venesection, in an attempt to make a definitive diagnosis in the infant. Early recognition of HIV infection allows appropriate and aggressive therapy, which may prolong survival. After the age of two years, a proportion of children will be "presumed uninfected", and follow-up can relax to six monthly until the age of 5 years. The ultimate outlook for children born to HIV infected women is unknown, and ideally, all children should be "tagged" in case future illnesses may be HIV related. It is accepted that follow-up should reach adolescent, although in practice, the stigma of the disease usually means that most parents will opt out of follow-up once the children reach school age. Figure 2 outlines one follow-up regime, used in Edinburgh, while table 2 summarises the surveillance programme. 
Management
The HIV affected family The majority of children infected with HIV have acquired the infection from their mother. Consideration must always be given to the health of parents, when child care needs or therapeutic interventions are discussed. With increasing numbers of young parents suffering ill health and requiring frequent hospital admission, close liaison must be developed with colleagues in the Social Work Department so that alternative care can be arranged for the children. The low rate of mother-child transmission in the western world (about 20%) means that in many families, a proportion of children born to HIV infected women will not be infected, but are by no means unaffected by illness and death in their families. AIDS orphans are those children bereaved by parental death, who may or may not be infected themselves. These children need help to come (b) Pneumocystis carinii pneumonia This is the most common AIDS defining illness in children, and when present in a child less than one year old, has a poor prognosis. In adults, independent predictors of PCP are persistent candidiasis, fever and a CD4+ T cell count of <200/mm3. A recent retrospective study in children reported a mortality of 59%, and showed that at the time of diagnosis of PCP, 36% of the children had CD4 counts of > 450/mm3, with 27% of infants having counts of > 1,000/mm3. This would limit the predictive value of CD4 counts.34 Recent guidelines for commencing prophylaxis against PCP are shown in Table 3 .5 Antiretroviral therapy Of the antiretroviral agents, most attention has focused on azidothymidine (AZT, zidovudine) which is the only drug with antiretroviral effects licensed to treat HIV infected children at present. The safety, tolerance of and therapeutic response to the The mechanisms and timing of HIV transmission from mother-to-child require further elucidation. Without knowing the exact time when infection in the fetus occurs, treatment protocols aimed at interrupting transmission cannot be developed. With results of studies suggesting intrapartum infection,14 37 the possibility exists that passive immunisation or active treatment with antiretroviral drugs given in the newborn period could prevent infection in the neonate.
The advent of new therapies which delay progression of HIV disease makes it imperative that those infected infants born to HIV seropositive mothers be recognised early, so that effective treatment strategies can be offered. At present, the presence of maternal HIV antibodies in the infant's circulation causes delays in diagnosis. Although many diagnostic techniques have been used, none have been shown to be useful for practical purposes. There is an urgent need for a comprehensive study to evaluate methods for the early diagnosis of HIV infection within the first six months of life. Also, the predictors of disease progression should be studied in order that those infected children with rapidly progressive disease can be offered treatment. It is likely that future developments in drug treatments will involve combination therapy, where several drugs are used to maximise efficacy while minimising toxicity.
In Africa and many Western countries, the majority of HIV infected children are infected because of mother-to-child transmission. Often, one or both parents are infected and in some families, there may be more than one infected child. The uninfected siblings are affected by illness and death in the family. The HIV affected family, and the millions of AIDS orphans of the future demand a high degree of collaboration between physicians caring for children and adults, hospital and community services, and staff working in social services and education departments.`T he resource implications, especially for developing countries, are phenomenal.
